The Distribution and Survival Association of Genetic Polymorphisms in Thai Patients with Hepatocellular Carcinoma According to Underlying Liver Disease
Genes · 2025
DOI: 10.3390/genes16070808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Theint Cho Zin Aung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Polymorphism, Single Nucleotide, Membrane Proteins. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B), NSRF, Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University.
Abstract (Originalsprache)
Background/Objectives: The influence of single-nucleotide polymorphisms (SNPs) on hepatocellular carcinoma (HCC) in terms of etiological factors remains to be explored. This study evaluated the distribution of PNPLA3 rs738409, TM6SF2 rs58542926, and HSD17B13 rs6834314 and overall survival of HCC patients with metabolic dysfunction-associated steatotic liver disease (MASLD-HCC) and viral-related HCC (VIRAL-HCC).
Methods
This study included 564 patients with HCC: 254 with MASLD-HCC and 310 with VIRAL-HCC. The SNPs were determined by real-time PCR using TaqMan assays.
Results
The mean ages of patients with MASLD-HCC and VIRAL-HCC were 68.4 vs. 60.9 years (p < 0.001), with a significant difference between groups. The prevalence of PNPLA3 GG genotype in MASLD-HCC was significantly higher in MASLD-HCC than in VIRAL-HCC (24.0% vs. 15.5%, OR = 1.86, 95% CI = 1.14–3.05, p = 0.009). Similarly, the prevalence of TM6SF2 TT genotype in MASLD-HCC and VIRAL-HCC was 7.1% vs. 2.6% (OR = 3.39, 95% CI = 1.36–9.21, p = 0.003), while HSD17B13 GG genotype in the corresponding groups was 7.1% vs. 12.6% (OR = 0.53, 95% CI = 0.27–1.01, p = 0.039). The overall median survival of MASLD-HCC was significantly shorter than that of the VIRAL-HCC group (42 vs. 66 months, p = 0.035). In Cox regression hazard analysis, HSD17B13 GG genotype was significantly associated with a lower mortality rate in MASLD-HCC (HR = 0.38, 95% CI = 0.18–0.81, p = 0.011). In contrast, PNPLA3 and TM6SF2 were not associated with overall survival in patients with MASLD-HCC or VIRAL-HCC.
Conclusions
Our data demonstrated that the prevalence of the SNPs significantly differed between MASLD-HCC and VIRAL-HCC. The HSD176B13 GG genotype was also associated with a survival benefit in Thai patients with MASLD-HCC. Thus, assessing the HSD176B13 genotype might be beneficial in risk stratification and potential therapeutic inhibition of HSD17B13 among patients with MASLD-HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
- Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Chulalongkorn University, Bangkok 10330, Thailand.
- Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 14000, Thailand.
- Metabolic Disease in Gastrointestinal and Urinary System Research Unit, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
ORCID-Profile: Theint Cho Zin Aung, Bootsakorn Boonkaew, Maneerat Chayanupatkul, Kittiyod Poovorawan, Natthaya Chuaypen, Pisit Tangkijvanich
Förderung
- The NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B)
- NSRF
- Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University
Zitieren
APA
Aung, T. C. Z., Boonkaew, B., Chayanupatkul, M., Poovorawan, K., Chuaypen, N., & Tangkijvanich, P. (2025). The Distribution and Survival Association of Genetic Polymorphisms in Thai Patients with Hepatocellular Carcinoma According to Underlying Liver Disease. Genes. https://doi.org/10.3390/genes16070808
Vancouver
Aung TCZ, Boonkaew B, Chayanupatkul M, Poovorawan K, Chuaypen N, Tangkijvanich P. The Distribution and Survival Association of Genetic Polymorphisms in Thai Patients with Hepatocellular Carcinoma According to Underlying Liver Disease. Genes. 2025. doi:10.3390/genes16070808
BibTeX
@article{Aung2025,
author = {Aung, Theint Cho Zin and Boonkaew, Bootsakorn and Chayanupatkul, Maneerat and Poovorawan, Kittiyod and Chuaypen, Natthaya and Tangkijvanich, Pisit},
title = {The Distribution and Survival Association of Genetic Polymorphisms in Thai Patients with Hepatocellular Carcinoma According to Underlying Liver Disease},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16070808}
}
EUVIMED